APPLICATION OF CONVOLUTIONAL NEURAL NETWORKS (CNN) FOR HEPATITIS C VIRUS (HCV) DISEASE DETECTION
DOI:
https://doi.org/10.30656/jsii.v12i2.10542Abstract
Hepatitis C (HCV) is a serious liver infection that can progress to cirrhosis or cancer, especially if early diagnosis is neglected. While conventional diagnostic methods such as ELISA are accurate, they are often limited in terms of efficiency and accessibility. This study introduces an innovative approach using a one-dimensional convolutional neural network (1D-CNN) for HCV disease classification, utilizing a Kaggle dataset consisting of 615 patient samples. The methodology includes data preprocessing such as handling missing values and transforming categorical variables to numeric values to ensure data readiness. The 1D-CNN model was trained using the Adam optimizer with ReLU activation functions in the convolution layer and sigmoid in the output layer. Model performance was comprehensively evaluated through accuracy, precision, recall, and F1-score metrics. The results showed that the 1D-CNN model achieved an accuracy of 83.74% on the training data and 81.30% on the testing data after hyperparameter tuning. This improvement is significant compared to the initial accuracy of only around 52%. However, the model exhibits a strong bias towards the majority class (Blood Donor), with very poor performance on minority classes such as Hepatitis, Fibrosis, and Cirrhosis. Nonetheless, this study contributes to the exploration of 1D-CNN for non-image medical data, which is still rarely studied. We conclude that despite the model's potential, further developments such as data balancing are needed to improve the model's overall generalization and accuracy.
Keywords: Deep Learning, Disease Classification, Hepatitis C, 1D CNN, Medical Diagnosis
References
[1] M. Martinello, S. S. Solomon, N. A. Terrault, and G. J. Dore, “Hepatitis C,” The Lancet, vol. 402, no. 10407, pp. 1085–1096, Sep. 2023, doi: 10.1016/S0140-6736(23)01320-X.
[2] M. Fasano, F. Ieva, M. Ciarallo, B. Caccianotti, and T. A. Santantonio, “Acute Hepatitis C: Current Status and Future Perspectives,” Viruses, vol. 16, no. 11, p. 1739, Nov. 2024, doi: 10.3390/v16111739.
[3] V. Lo Re, J. C. Price, S. Schmitt, N. Terrault, D. Bhattacharya, and A. Aronsohn, “The obstacle is the way: Finding a path to hepatitis C elimination,” Hepatology, vol. 80, no. 1, pp. 3–7, Jul. 2024, doi: 10.1097/HEP.0000000000000807.
[4] A. S. Baber, B. Suganthan, and R. P. Ramasamy, “Current advances in Hepatitis C diagnostics,” J Biol Eng, vol. 18, no. 1, p. 48, Sep. 2024, doi: 10.1186/s13036-024-00443-2.
[5] I. Argirion et al., “Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort,” Cancers, vol. 14, no. 21, p. 5280, Oct. 2022, doi: 10.3390/cancers14215280.
[6] C. R. Maturana et al., “Advances and challenges in automated malaria diagnosis using digital microscopy imaging with artificial intelligence tools: A review,” Front. Microbiol., vol. 13, p. 1006659, Nov. 2022, doi: 10.3389/fmicb.2022.1006659.
[7] M. Darvishi et al., “Nanodiagnostics in global eradication of hepatitis C virus,” Clinica Chimica Acta, vol. 565, p. 120013, Jan. 2025, doi: 10.1016/j.cca.2024.120013.
[8] G. Bulusu, K. E. C. Vidyasagar, M. Mudigonda, and M. J. Saikia, “Cancer Detection Using Artificial Intelligence: A Paradigm in Early Diagnosis,” Arch Computat Methods Eng, vol. 32, no. 4, pp. 2365–2403, May 2025, doi: 10.1007/s11831-024-10209-0.
[9] Y. Kumar, S. Gupta, R. Singla, and Y.-C. Hu, “A Systematic Review of Artificial Intelligence Techniques in Cancer Prediction and Diagnosis,” Arch Computat Methods Eng, vol. 29, no. 4, pp. 2043–2070, Jun. 2022, doi: 10.1007/s11831-021-09648-w.
[10] N. Sharfina and N. G. Ramadhan, “Analisis SMOTE Pada Klasifikasi Hepatitis C Berbasis Random Forest dan Naïve Bayes,” JOINTECS, vol. 8, no. 1, p. 33, Jun. 2023, doi: 10.31328/jointecs.v8i1.4456.
[11] R. A. Charisma, S. Pamungkas, R. A. Saputra, N. G. Ramadhan, and F. D. Adhinata, “Analisis Penerapan Metode Ensembled Learning Decision Tree Pada Klasifikasi Virus Hepatitis C,” JoSYC, vol. 3, no. 4, pp. 405–409, Sep. 2022, doi: 10.47065/josyc.v3i4.2064.
[12] A. Drobo et al., “Application of artificial neural networks in diagnosis of Hepatitis C,” in 2022 XXVIII International Conference on Information, Communication and Automation Technologies (ICAT), Sarajevo, Bosnia and Herzegovina: IEEE, Jun. 2022, pp. 1–5. doi: 10.1109/ICAT54566.2022.9811126.
[13] Arya Satya Pratama, Suci Maela Sari, Maila Faiza Hj, Moh Badwi, and Mochammad Isa Anshori, “Pengaruh Artificial Intelligence, Big Data Dan Otomatisasi Terhadap Kinerja SDM Di Era Digital,” jupiman, vol. 2, no. 4, pp. 108–123, Oct. 2023, doi: 10.55606/jupiman.v2i4.2739.
[14] K. Surendro, M. I. C. Rachmatullah, and J. Santoso, “Improving 1d Convolutional Neural Network (1d Cnn) Performance in Processing Tabular Datasets Using Principal Component Analysis,” Oct. 17, 2022. doi: 10.21203/rs.3.rs-2149472/v1.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Fathorrozi Ariyanto Fathorrozi, Indra Maulana, Moh. Aminollah Hamzah, Aang Kisnu Darmawan

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
-
Author(s)' Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
- Information
- Notice about change in the copyright policy of the journal 'Jurnal Sistem Informasi (JSiI)' : "From Vol 1, onwards the copyright of the article published in the journal 'Jurnal Sistem Informasi' will be retained by the author"








.jpg)
